Literature DB >> 9397247

Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study.

S D Nesbitt1, J V Amerena, E Grant, K A Jamerson, H Lu, A Weder, S Julius.   

Abstract

We evaluated time-related blood pressure trends in the Tecumseh study participants, none of whom received antihypertensive treatment. At baseline the blood pressures were measured in the field clinic and by self measurement at home (twice daily for 7 days). After a mean of 3.2 +/- 0.42 years, the clinic and home pressure readings were repeated. Nine hundred forty-six subjects had clinic and home blood pressure readings at baseline. Of these 735 (380 men, 355 women; average age, 32 years) also completed the second examination. Blood pressure, morphometric data, and biochemical measures at the first examination were used as predictors of future clinic blood pressures. Five hundred ninety-six subjects were normotensive on both examinations (81%). Of 79 subjects (10.7%) with clinic hypertension (> 140 mg Hg systolic or 90 mm Hg diastolic) at baseline, 38 remained hypertensive ("sustained hypertension") and 41 became normotensive ("transient hypertension") after 3 years. Another 60 normotensives at baseline (10.4%) became hypertensive on second examination ("de novo hypertensives"; incidence; 8.1%). The home blood pressure readings on both examinations were reproducible. The three hypertensive groups had elevated home blood pressure, were overweight, had dyslipidemia, and higher insulin values. Only the home blood pressure proved predictive of subsequent blood pressure trends. A home blood pressure of 128 and 83 mm Hg or higher detected "sustained" hypertension with a 48% sensitivity and 93% specificity. Readings of 120 and 80 mm Hg or lower predicted future normotension with a 45% sensitivity and a 91% specificity. We conclude that self determination of the blood pressure at home is useful in the management of borderline hypertension. An algorithm for the management of these patients is proposed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397247     DOI: 10.1016/s0895-7061(97)00267-7

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Insulin resistance and risk of incident hypertension among men.

Authors:  Tai-Shuan Lai; Gary C Curhan; John P Forman
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

2.  Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trial.

Authors:  Heather M Johnson; Lisa Sullivan-Vedder; KyungMann Kim; Patrick E McBride; Maureen A Smith; Jamie N LaMantia; Jennifer T Fink; Megan R Knutson Sinaise; Laura M Zeller; Diane R Lauver
Journal:  Contemp Clin Trials       Date:  2019-01-21       Impact factor: 2.226

Review 3.  Home blood pressure monitoring: primary role in hypertension management.

Authors:  George S Stergiou; Anastasios Kollias; Marilena Zeniodi; Nikos Karpettas; Angeliki Ntineri
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

4.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

5.  Reliability of automated blood pressure devices used by hypertensive patients.

Authors:  William C W Wong; Ivan K L Shiu; Thomas M T Hwong; James A Dickinson
Journal:  J R Soc Med       Date:  2005-03       Impact factor: 18.000

6.  Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR).

Authors:  Maria Shkolnikova; Svetlana Shalnova; Vladimir M Shkolnikov; Victoria Metelskaya; Alexander Deev; Evgueni Andreev; Dmitri Jdanov; James W Vaupel
Journal:  BMC Public Health       Date:  2009-08-13       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.